MeInWe - Personalized Medicine in the Welfare State
![](/fileadmin/news_import/personalized_medicine.jpg)
Andreas Roepstorff is member of the Core Research Group in large research project supported by the Carlsberg Foundation.
MeInWe explores how strategies of tailoring diagnosis, treatment and prevention to individual genetic variability challenge existing ethical, organizational and regulatory frameworks in medicine.
The project asks two central questions:
- How is “the personal” understood and established when genomic data are applied and exchanged in Danish health care?
- Which collectivities—e.g. species, ethnicity, nation, health care services, and ultimately the welfare state— are implied in constituting “the personal”?
With these questions MeInWe critically assesses how strategies of personalized medicine draw boundaries around the person (the me) and how collectivities (the we) are shaped and negotiated in creating knowledge about the individual. By empirically investigating the introduction of whole genome sequenzing in specific sites of research, clinic and patient lives, MeInWe examines and actively contributes to discussions of how personalized medicine introduces new ways of understanding and approaching health and disease.
The project is supported by the Carlsberg Foundation with 15 M DKK over the period September 2017 to February 2022.
Read more about the project MeInWe
Press release from the Carlsberg Foundation (in Danish)
Contact: Professor Andreas Roepstorff